New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test, Stockholm3, is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A new blood test known as Stockholm3 has demonstrated the ability to detect 90% of aggressive prostate cancer cases. This performance exceeds that of current screenings, specifically the PSA test.
Coverage from Fox News, Conexiant, and Oncodaily emphasizes the test's ability to detect more significant cancers than the PSA method. Additionally, BioSpectrum Asia reports that researchers from India and New Zealand are exploring a DNA-based approach to further improve detection.
Future developments involve the continued exploration of DNA-based detection methods and ongoing comparisons between Stockholm3 and PSA screening performance.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
What is the name of the new blood test?
The test is called Stockholm3.
How does Stockholm3 compare to the PSA test?
According to coverage, Stockholm3 detected more significant prostate cancers and beats current screenings by detecting 90% of aggressive cases.
Who is researching DNA-based approaches to detection?
Researchers from India and New Zealand are exploring these approaches.
Coverage (4)
- Indo-NZ researchers explore DNA-based approach to improve prostate cancer detection BioSpectrum Asia · 5h ago
- Adam B. Weiner: Can Stockholm3 Outperform PSA for Prostate Cancer Screening? Oncodaily · 5h ago
- Stockholm3 Detected More Significant Prostate Cancers Than PSA Conexiant · 5h ago
- New blood test detects 90% of aggressive prostate cancer cases, beating current screenings Fox News · 5h ago broke it first
People, places & organizations
Topics
Related trends
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
Thousands of men with prostate cancer can now access high-powered radiotherapy via the NHS to treat early-stage disease more efficiently.
Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is outperforming traditional PSA screenings in detecting clinically significant prostate cancer.